NCT05607992

Brief Summary

The purpose of the present pilot study is to evaluate the feasibility and potential efficacy of a brief, internet-delivered CBT protocol provided early after acute coronary syndrome (ACS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 7, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

May 18, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2024

Completed
Last Updated

August 27, 2024

Status Verified

August 1, 2024

Enrollment Period

1.3 years

First QC Date

October 27, 2022

Last Update Submit

August 26, 2024

Conditions

Keywords

Acute coronary syndromePosttraumatic stress disorderCardiac anxietyCognitive behavioral therapy

Outcome Measures

Primary Outcomes (4)

  • Seattle Angina Questionnaire

    A measure of coronary artery disease on five scales: physical limitation scale, anginal stability scale, anginal frequency scale, treatment satisfaction scale, and the disease perception scale. With a score ranging from 0 to 100. A higher score indicating a better quality of life.

    Baseline to 3 months

  • Acceptability: Client satisfaction Questionnaire

    Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment.

    Baseline to 5 weeks

  • Percentage of enrolled participants who complete the treatment

    Feasibility of the intervention components will be assessed by \>60% assessed as treatment completers. Descriptive analysis will also provide number of messages and therapist time.

    Baseline to 5 weeks

  • Adverse events

    Potential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively').

    Baseline to 5 weeks

Secondary Outcomes (41)

  • Seattle Angina Questionnaire

    Baseline to 5 weeks

  • Seattle Angina Questionnaire

    Baseline to 7 months

  • Seattle Angina Questionnaire

    Change over 5 measurement points measured from baseline and weekly for 5 weeks during treatment

  • The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5

    Baseline to 5 weeks

  • The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5

    Baseline to 3 months

  • +36 more secondary outcomes

Other Outcomes (4)

  • Adverse events

    Baseline to 3 months

  • Adverse events

    Baseline to 7 months

  • Adverse events

    5 measurement points measured from baseline and weekly for 5 weeks during treatment

  • +1 more other outcomes

Study Arms (2)

Brief exposure-based CBT

EXPERIMENTAL

* Patient education: Common reactions following ACS. The role of PTS, cardiac anxiety and avoidance behavior on quality of life and physical health and health behaviors. * Labeling i.e., describe cardiac-related symptoms, thoughts, and feelings. * Imaginal exposure to reduce PTSS: Imaginal processing and revisiting of the memory of the ACS * Interoceptive exposure to physical sensations (e.g., palpitations due to physical activity) to reduce fear of these symptoms. * Gradual exposure in-vivo to avoided situations, activities and physical activity. Continuously use labeling while conducting exposure exercises. * Relapse prevention: Prevention of relapse into avoidance behaviors by identifying risk situations and encouragement of maintaining a healthy physically active lifestyle.

Behavioral: Brief exposure-based CBT

Waitlist control

NO INTERVENTION

The waitlist control will be offered an opportunity to participate in the intervention after the 2-month intervention evaluation period.

Interventions

The 5-week intervention is psychologist-guided and delivered via text-based interactive online treatment modules, where patients complete weekly homework assignments and have regular online contact with psychologists with training in CBT for cardiac disease. Key components include imaginal exposure of the ACS event, interoceptive exposure through at home physical activity that stimulats the CV system, exposure in-vivo to reduce avoided situations, and activities to enhance physical activity wellbeing. Labeling (i.e., describing cardiac-related symptoms, thoughts, and feelings) will be used continuously during treatment to enhance the effect of exposure.

Brief exposure-based CBT

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (A) ACS ≥ four weeks to six months before assessment (MI type 1 STEMI/NSTEMI and UA)
  • (B) Age 18-80 years
  • (C) Symptoms of PTSD and/or cardiac anxiety that leads to distress and/or interferes with daily life (PCL5; ≥ 10, CAQ: ≥20)
  • (D) On standard of care medical treatment for the cardiac condition according to Swedish cardiovascular guidelines
  • (E) Ability to read and write in Swedish.

You may not qualify if:

  • (F) Heart failure with severe systolic dysfunction (ejection fraction ≤ 35%)
  • (G) Significant valvular disease
  • (H) Planned coronary artery bypass surgery or percutaneous interventions
  • (I) Any medical restriction to physical exercise
  • (J) Severe uncontrolled medical illness i.e., advanced cancer
  • (K) Grade 3 hypertension (i.e., blood pressure ≥ 180 systolic and/or 110 diastolic)
  • (L) Severe psychiatric disorder, active suicidal ideations or cognitive impairment that precludes provision of informed consent or study activities
  • (M) Alcohol dependency
  • (N) Ongoing psychological treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Karolinska University Hospital

Stockholm, 11635, Sweden

Location

Karolinska Institutet

Stockholm, Sweden

Location

MeSH Terms

Conditions

Psychological TraumaAcute Coronary SyndromeStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, PhD, Lic. psychologist

Study Record Dates

First Submitted

October 27, 2022

First Posted

November 7, 2022

Study Start

May 18, 2023

Primary Completion

August 21, 2024

Study Completion

August 21, 2024

Last Updated

August 27, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations